USA - NASDAQ:NERV - US6033802058 - Common Stock
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 11.23M | 1.44M | -30.01M | -32.11M | -49.91M | |||
| Depreciation Amortization | 12.40K | 22.50K | 31.00K | 10.00K | 0 | |||
| Income Taxes - Deferred | undefined | null | null | null | -1.80M | |||
| Accounts Payable And Accrued Liabilities | undefined | undefined | undefined | undefined | undefined | |||
| Change In Working Capital | -1.44M | -320.60K | 4.94M | -4.06M | 260.00K | |||
| Interest Paid | undefined | null | null | null | 0 | |||
| Taxes Paid | undefined | null | null | null | null | |||
| Other non cash items | -25.43M | -20.69M | 10.25M | 11.52M | 26.85M | |||
| OPERATING CASH FLOW | -15.66M | -19.55M | -14.78M | -24.65M | -24.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | undefined | null | 0 | -20.00K | null | |||
| Other Investing Activity | undefined | 0 | null | null | 0 | |||
| INVESTING CASH FLOW | undefined | 0 | 0 | -20.00K | 0 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | undefined | null | null | null | null | |||
| Stock Issued/Repurchased | undefined | null | 20.00M | 0 | 0 | |||
| Dividend Paid | undefined | null | null | null | null | |||
| Other Financing Activity | undefined | null | -396.30K | 0 | 60.00M | |||
| FINANCING CASH FLOW | undefined | null | 19.60M | 0 | 60.00M | |||
| Exchange Rate Effect | undefined | null | null | null | null | |||
| CHANGE IN CASH | -15.66M | -19.55M | 4.82M | -24.67M | 35.40M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -15.66M | -19.55M | -14.78M | -24.65M | -24.60M | |||
| Capital Expenditure | undefined | null | 0 | -20.00K | null | |||
| FREE CASH FLOW | -15.66M | -19.55M | -14.78M | -24.67M | -24.60M | |||
All data in USD